Publications in collaboration with researchers from Instituto de Salud Carlos III (33)

2024

  1. Connective tissue amyloidosis in patients referred for orthopedic surgery. CONNECT-AMY study

    Medicina Clinica

  2. Diagnosis of transthyretin amyloidosis in patients with established cardiomyopathy

    Revista Espanola de Cardiologia, Vol. 77, Núm. 4, pp. 347-349

  3. Incidence and causes of hospitalization in patients with transthyretin (ATTR-CA) and light chain (AL-CA) cardiac amyloidosis

    Medicina Clinica, Vol. 162, Núm. 7, pp. e1-e7

  4. Prognostic impact of chronic obstructive pulmonary disease and bronchial asthma in patients with heart failure

    Revista Clinica Espanola, Vol. 224, Núm. 3, pp. 123-132

  5. Prognostic value of the tricuspid annular plane systolic excursion/systolic pulmonary artery pressure ratio in cardiac amyloidosis

    Revista Espanola de Cardiologia, Vol. 77, Núm. 8, pp. 634-644

  6. Protocolized Natriuresis-Guided Decongestion Improves Diuretic Response: The Multicenter ENACT-HF Study

    Circulation: Heart Failure, Vol. 17, Núm. 1, pp. E011105

  7. Reduced mitochondrial pyruvate carrier expression in hearts with heart failure and reduced ejection fraction patients: ischemic vs. non-ischemic origin

    Frontiers in Cardiovascular Medicine, Vol. 11

  8. Use of SGLT2i in patients with transthyretin amyloid cardiomyopathy: prevalence and safety in a Spanish prospective cohort

    Revista Espanola de Cardiologia, Vol. 77, Núm. 4, pp. 349-352

2023

  1. Development and Validation of a Prediction Model and Score for Transthyretin Cardiac Amyloidosis Diagnosis: T-Amylo

    JACC: Cardiovascular Imaging, Vol. 16, Núm. 12, pp. 1567-1580

  2. Employment situation of young cardiologists in Spain

    Revista Espanola de Cardiologia, Vol. 76, Núm. 3, pp. 204-206

  3. Soluble HLA-G levels in heart transplant recipients: Dynamics and correlation with clinical outcomes

    Transplant Immunology, Vol. 76

2022

  1. Beta-Blocker Exposure and Survival in Patients With Transthyretin Amyloid Cardiomyopathy

    Mayo Clinic Proceedings, Vol. 97, Núm. 2, pp. 261-273

  2. Cancer in patients with heart failure: Incidence, risk factors and prognostic impact

    European Journal of Internal Medicine, Vol. 105, pp. 89-96

  3. Cardiac amyloidosis: Description of a series of 143 cases

    Medicina Clinica, Vol. 159, Núm. 5, pp. 207-213

  4. Real world comparison of spironolactone and eplerenone in patients with heart failure

    European Journal of Internal Medicine, Vol. 97, pp. 86-94

  5. Syncope in patients with transthyretin amyloid cardiomyopathy: clinical features and outcomes

    Postgraduate Medicine, Vol. 134, Núm. 4, pp. 420-428

  6. Udpate on the diagnostic and therapeutic approach to transthyretin cardiac amyloidosis

    REC: CardioClinics, Vol. 57, pp. S19-S27

2021

  1. Determinants of maximal oxygen uptake in patients with heart failure

    ESC Heart Failure, Vol. 8, Núm. 3, pp. 2002-2008

  2. Light chain and transthyretin cardiac amyloidosis: Clinical characteristics, natural history and prognostic factors

    Medicina Clinica, Vol. 156, Núm. 8, pp. 369-378

  3. Rationale and Design of the Efficacy of a Standardized Diuretic Protocol in Acute Heart Failure Study

    ESC Heart Failure, Vol. 8, Núm. 6, pp. 4685-4692